http://www.cnr.it/ontology/cnr/individuo/unitaDiPersonaleEsterno/ID8266
Alberto Maria Martelli
- Type
- Label
- Alberto Maria Martelli (literal)
- Alberto Maria Martelli (literal)
- Partecipa a commessa
- Persona in rapporto
- Autore CNR di
- Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistance. (Articolo in rivista) (Prodotto della ricerca)
- Synergistic proapoptotic activity of recombinant trail plus the Akt inhibitor perifosine in acute myelogenous leukemia cells (Articolo in rivista) (Prodotto della ricerca)
- Catalytic activity of nuclear PLC-beta(1) is required for its signalling function during C2C12 differentiation. (Articolo in rivista) (Prodotto della ricerca)
- The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute (Articolo in rivista) (Prodotto della ricerca)
- Targeting prostate cancer based on signal transduction and cell cycle pathways. (Articolo in rivista) (Prodotto della ricerca)
- DGK? is degraded through the cytoplasmic ubiquitin-proteasome system under excitotoxic conditions, which causes neuronal apoptosis because of aberrant cell cycle reentry. (Articolo in rivista) (Prodotto della ricerca)
- Morphological and biochemical patterns in skeletal muscle apoptosis. (Articolo in rivista) (Prodotto della ricerca)
- Dominant roles of the Raf/MEK/ERK pathway in cell cycle progression, prevention of apoptosis and sensitivity to chemotherapeutic drugs. (Articolo in rivista) (Prodotto della ricerca)
- Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Nuclear phosphoinositides and their roles in cell biology and disease. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy. (Articolo in rivista) (Prodotto della ricerca)
- Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia. (Articolo in rivista) (Prodotto della ricerca)
- Synergistic induction of PI-PLC²1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromes. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Exploiting p53 status to enhance effectiveness of chemotherapy by lowering associated toxicity. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- The cyclin-dependent kinase inhibitor roscovitine and the nucleoside analog sangivamycin induce apoptosis in caspase-3 deficient breast cancer cells independent of caspase mediated P-glycoprotein cleavage: implications for therapy of drug resistant breast (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Dual inhibition of class IA phosphatidylinositol 3-kinase and mammalian target of rapamycin as a new therapeutic option for T-cell acute lymphoblastic leukemia. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- PKR is activated in MDS patients and its subcellular localization depends on disease severity. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Enhancing therapeutic efficacy by targeting non-oncogene addicted cells with combinations of signal transduction inhibitors and chemotherapy. (Articolo in rivista) (Prodotto della ricerca)
- Identification of a functional nuclear export sequence in diacylglycerol kinase-zeta (Articolo in rivista) (Prodotto della ricerca)
- Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- PKR activity is required for acute leukemic cell maintenance and growth: A role for PKR-mediated phosphatase activity to regulate GSK-3 phosphorylation. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Nuclear inositides: PI-PLC signaling in cell growth, differentiation and pathology (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Intranuclear 3'-phosphoinositide metabolism and apoptosis protection in PC12 cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Involvement of Akt-1 and mTOR in sensitivity of breast cancer to targeted therapy (Articolo in rivista) (Prodotto della ricerca)
- Inositide signaling: Nuclear targets and involvement in myelodysplastic syndromes. (Articolo in rivista) (Prodotto della ricerca)
- Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells. (Articolo in rivista) (Prodotto della ricerca)
- Nuclear phospholipase C beta1 and cellular differentiation. (Articolo in rivista) (Prodotto della ricerca)
- Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts. (Articolo in rivista) (Prodotto della ricerca)
- PI-PLCbeta-1 and activated Akt levels are linked to azacitidine responsiveness in high-risk myelodysplastic syndromes. (Articolo in rivista) (Prodotto della ricerca)
- The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients. (Articolo in rivista) (Prodotto della ricerca)
- Nuclear phosphatidylinositol 3,4,5-trisphosphate, phosphatidylinositol 3-kinase, Akt, and PTen: emerging key regulators of anti-apoptotic signaling and carcinogenesis. (Articolo in rivista) (Prodotto della ricerca)
- Nuclear diacylglycerol kinases: emerging downstream regulators in cell signaling networks. (Articolo in rivista) (Prodotto della ricerca)
- Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside. (Articolo in rivista) (Prodotto della ricerca)
- CTLA-4 expressed by chemoresistant, as well as untreated, myeloid leukaemia cells can be targeted with ligands to induce apoptosis. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors (Articolo in rivista) (Prodotto della ricerca)
- Phosphoinositide-Phospholipase C {beta}1 Mono-Allelic Deletion Is Associated With Myelodysplastic Syndromes Evolution Into Acute Myeloid Leukemia (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Targeting the leukemic stem cell: the Holy Grail of leukemia therapy. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- PKC-zeta expression is lower in osteoblasts from arthritic patients: IL1-beta and TNF-alpha induce a similar decrease in non-arthritic human osteoblasts. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia. (Articolo in rivista) (Prodotto della ricerca)
- The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- The phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin signaling network and the control of normal myelopoiesis. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulin-like growth factor-I secretion. (Articolo in rivista) (Prodotto della ricerca)
- Nuclear inositide signaling: an appraisal of phospholipase C beta 1 behavior in myelodysplastic and leukemia cells. (Articolo in rivista) (Prodotto della ricerca)
- Toxicity of antimony trioxide nanoparticles on human hematopoietic progenitor cells and comparison to cell lines. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Nuclear inositide signaling in myelodysplastic syndromes. (Articolo in rivista) (Prodotto della ricerca)
- The emerging multiple roles of nuclear Akt. (Articolo in rivista) (Prodotto della ricerca)
- Inositide signaling in the nucleus: from physiology to pathology. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Activity of the Novel Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235 against T-Cell Acute Lymphoblastic Leukemia. (Articolo in rivista) (Prodotto della ricerca)
- The emerging role of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in normal myelopoiesis and leukemogenesis. (Articolo in rivista) (Prodotto della ricerca)
- Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Nuclear diacylglycerol kinase-zeta is a negative regulator of cell cycle progression in C2C12 mouse myoblasts. (Articolo in rivista) (Prodotto della ricerca)
- The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation. (Articolo in rivista) (Prodotto della ricerca)
- Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Multiple forms of PKR present in the nuclei of acute leukemia cells represent an active kinase that is responsive to stress. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: Eliminating activity by targeting at different levels. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- TIS21/BTG2/PC3 and cyclin D1 are key determinants of nuclear diacylglycerol kinase-zeta-dependent cell cycle arrest. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Activity of the selective I?B kinase inhibitor BMS-345541 against T-cell acute lymphoblastic leukemia: involvement of FOXO3a. (Articolo in rivista) (Prodotto della ricerca)
- Coautore
- Nome
- Cognome
- Afferisce a
- Ha pubblicazioni con
Incoming links:
- Ha afferente
- Coautore
- Ha pubblicazioni con
- Partecipazione di
- Rapporto con persona
- Autore CNR
- PKC-zeta expression is lower in osteoblasts from arthritic patients: IL1-beta and TNF-alpha induce a similar decrease in non-arthritic human osteoblasts. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulin-like growth factor-I secretion. (Articolo in rivista) (Prodotto della ricerca)
- Nuclear inositide signaling: an appraisal of phospholipase C beta 1 behavior in myelodysplastic and leukemia cells. (Articolo in rivista) (Prodotto della ricerca)
- PI-PLCbeta-1 and activated Akt levels are linked to azacitidine responsiveness in high-risk myelodysplastic syndromes. (Articolo in rivista) (Prodotto della ricerca)
- Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells. (Articolo in rivista) (Prodotto della ricerca)
- Nuclear phospholipase C beta1 and cellular differentiation. (Articolo in rivista) (Prodotto della ricerca)
- Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors (Articolo in rivista) (Prodotto della ricerca)
- Inositide signaling: Nuclear targets and involvement in myelodysplastic syndromes. (Articolo in rivista) (Prodotto della ricerca)
- Phosphoinositide-Phospholipase C {beta}1 Mono-Allelic Deletion Is Associated With Myelodysplastic Syndromes Evolution Into Acute Myeloid Leukemia (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Morphological and biochemical patterns in skeletal muscle apoptosis. (Articolo in rivista) (Prodotto della ricerca)
- Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Dominant roles of the Raf/MEK/ERK pathway in cell cycle progression, prevention of apoptosis and sensitivity to chemotherapeutic drugs. (Articolo in rivista) (Prodotto della ricerca)
- Synergistic induction of PI-PLC²1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromes. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia. (Articolo in rivista) (Prodotto della ricerca)
- Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy. (Articolo in rivista) (Prodotto della ricerca)
- Nuclear phosphoinositides and their roles in cell biology and disease. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts. (Articolo in rivista) (Prodotto della ricerca)
- CTLA-4 expressed by chemoresistant, as well as untreated, myeloid leukaemia cells can be targeted with ligands to induce apoptosis. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Nuclear diacylglycerol kinases: emerging downstream regulators in cell signaling networks. (Articolo in rivista) (Prodotto della ricerca)
- Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside. (Articolo in rivista) (Prodotto della ricerca)
- Nuclear phosphatidylinositol 3,4,5-trisphosphate, phosphatidylinositol 3-kinase, Akt, and PTen: emerging key regulators of anti-apoptotic signaling and carcinogenesis. (Articolo in rivista) (Prodotto della ricerca)
- Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- PKR is activated in MDS patients and its subcellular localization depends on disease severity. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Dual inhibition of class IA phosphatidylinositol 3-kinase and mammalian target of rapamycin as a new therapeutic option for T-cell acute lymphoblastic leukemia. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- The cyclin-dependent kinase inhibitor roscovitine and the nucleoside analog sangivamycin induce apoptosis in caspase-3 deficient breast cancer cells independent of caspase mediated P-glycoprotein cleavage: implications for therapy of drug resistant breast (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- PKR activity is required for acute leukemic cell maintenance and growth: A role for PKR-mediated phosphatase activity to regulate GSK-3 phosphorylation. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Nuclear inositides: PI-PLC signaling in cell growth, differentiation and pathology (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Identification of a functional nuclear export sequence in diacylglycerol kinase-zeta (Articolo in rivista) (Prodotto della ricerca)
- Enhancing therapeutic efficacy by targeting non-oncogene addicted cells with combinations of signal transduction inhibitors and chemotherapy. (Articolo in rivista) (Prodotto della ricerca)
- Inositide signaling in the nucleus: from physiology to pathology. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Nuclear inositide signaling in myelodysplastic syndromes. (Articolo in rivista) (Prodotto della ricerca)
- Multiple forms of PKR present in the nuclei of acute leukemia cells represent an active kinase that is responsive to stress. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation. (Articolo in rivista) (Prodotto della ricerca)
- Nuclear diacylglycerol kinase-zeta is a negative regulator of cell cycle progression in C2C12 mouse myoblasts. (Articolo in rivista) (Prodotto della ricerca)
- Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute (Articolo in rivista) (Prodotto della ricerca)
- Targeting prostate cancer based on signal transduction and cell cycle pathways. (Articolo in rivista) (Prodotto della ricerca)
- Catalytic activity of nuclear PLC-beta(1) is required for its signalling function during C2C12 differentiation. (Articolo in rivista) (Prodotto della ricerca)
- Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistance. (Articolo in rivista) (Prodotto della ricerca)
- Synergistic proapoptotic activity of recombinant trail plus the Akt inhibitor perifosine in acute myelogenous leukemia cells (Articolo in rivista) (Prodotto della ricerca)
- TIS21/BTG2/PC3 and cyclin D1 are key determinants of nuclear diacylglycerol kinase-zeta-dependent cell cycle arrest. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Toxicity of antimony trioxide nanoparticles on human hematopoietic progenitor cells and comparison to cell lines. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- The phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin signaling network and the control of normal myelopoiesis. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- The emerging role of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in normal myelopoiesis and leukemogenesis. (Articolo in rivista) (Prodotto della ricerca)
- Activity of the Novel Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235 against T-Cell Acute Lymphoblastic Leukemia. (Articolo in rivista) (Prodotto della ricerca)
- Exploiting p53 status to enhance effectiveness of chemotherapy by lowering associated toxicity. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Intranuclear 3'-phosphoinositide metabolism and apoptosis protection in PC12 cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients. (Articolo in rivista) (Prodotto della ricerca)
- Involvement of Akt-1 and mTOR in sensitivity of breast cancer to targeted therapy (Articolo in rivista) (Prodotto della ricerca)
- Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia. (Articolo in rivista) (Prodotto della ricerca)
- Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Activity of the selective I?B kinase inhibitor BMS-345541 against T-cell acute lymphoblastic leukemia: involvement of FOXO3a. (Articolo in rivista) (Prodotto della ricerca)
- Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- DGK? is degraded through the cytoplasmic ubiquitin-proteasome system under excitotoxic conditions, which causes neuronal apoptosis because of aberrant cell cycle reentry. (Articolo in rivista) (Prodotto della ricerca)
- The emerging multiple roles of nuclear Akt. (Articolo in rivista) (Prodotto della ricerca)
- Targeting the leukemic stem cell: the Holy Grail of leukemia therapy. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: Eliminating activity by targeting at different levels. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
